Next Generation Sequencing Services Market by Service Type (Targeted Sequencing, Exome, RNA-Seq, ChIP Sequencing), Technology (Sequencing by Synthesis, Nanopore, SMRT), Application (Clinical Diagnosis, Biomarker Discovery), and End User - Global Forecast to 2025

  • Report ID:MRHC - 104341
  • Pages: 193
  • Oct 2019
  • Formats*: PDF
  • Category: Healthcare

1. Introduction
    1.1. Market Ecosystem
    1.2. Currency and Limitations
           1.2.1. Currency
           1.2.2. Limitations
    1.3. Key Stakeholders

2. Research Methodology
    2.1. Research Process
           2.1.1. Secondary Research
           2.1.2. Primary Research
           2.1.3. Market Size Estimation

3. Executive Summary

4. Market Insights
    4.1. Introduction
    4.2. Drivers
           4.2.1. Plummeting Cost of Sequencing Procedures
           4.2.2. Technological Advancements in NGS Services
           4.2.3. Increase in Genome Mapping Programs
           4.2.4. High Cost of Sequencing Infrastructure
    4.3. Restraints
           4.3.1. Lack of Skilled Professionals for Efficient NGS Sample Preparation and Analysis
    4.4. Opportunities
           4.4.1. Increasing Applications in Cancer and Agrigenomics Research
           4.4.2. Analysis of Complex Sequencing Data
    4.5. Challenges
           4.5.1. Accuracy & Standardization Concerns in Diagnostic Testing
           4.5.2. Installation of In-House Sequencing Facilities in Large Hospitals and Academic Universities
           4.5.3. Ethical Issues Related to Non-Invasive Prenatal Testing

5. Next Generation Sequencing Services Market, by Service Type
    5.1. Introduction
    5.2. Targeted Sequencing 
    5.3. RNA Sequencing Services
    5.4. Exome Sequencing Services
    5.5. DE Novo Sequencing Services
    5.6. ChIP Sequencing Services
    5.7. Whole Genome Sequencing
    5.8. Methyl Sequencing
    5.9. Other Services

6. Next Generation Sequencing Services Market, by Technology
    6.1. Introduction
    6.2. Sequencing by Synthesis (SBS)
    6.3. Ion Semiconductor Sequencing (IOS)
    6.4. Single Molecule Real Time Sequencing (SMRT)
    6.5. Nanopore Sequencing
    6.6. True Single Molecule Sequencing (tSMS)

7. Next Generation Sequencing Services Market, by Application
    7.1. Introduction
    7.2. Diagnostics
    7.3. Drug Discovery
    7.4. Biomarker Discovery
    7.5. Agriculture & Animal Research
    7.6. Other Applications

8. Next Generation Sequencing Services Market, by End User
    8.1. Introduction
    8.2. Hospitals & Clinics
    8.3. Pharmaceutical & Biotechnology Companies
    8.4. Academics & Research Institutes
    8.5. Other End Users

9. Next Generation Sequencing Services Market, by Geography
    9.1. Introduction
    9.2. North America
           9.2.1. U.S.
           9.2.2. Canada
    9.3. Europe
           9.3.1. Germany
           9.3.2. France
           9.3.3. U.K.
           9.3.4. Italy
           9.3.5. Spain
           9.3.6. Rest of Europe
    9.4. Asia Pacific
           9.4.1. Japan
           9.4.2. China
           9.4.3. India
           9.4.4. Rest of Asia-Pacific
    9.5. Latin America
    9.6. Middle East & Africa

10. Competitive Landscape
      10.1. Introduction
      10.2. Key Growth Strategies
      10.3. Competitive Benchmarking
      10.4. Market Share Analysis (2018)
               10.4.1. Eurofins Scientific SE
               10.4.2. Illumina, Inc.
               10.4.3. PerkinElmer, Inc.
               10.4.4. Qiagen N.V.

11. Company Profiles (Business Overview, Financial Overview, Service Portfolio, Strategic Developments)
      11.1. Illumina, Inc.
      11.2. Qiagen N.V.
      11.3. PerkinElmer, Inc.
      11.4. Eurofins Scientific SE
      11.5. Macrogen, Inc.
      11.6. LGC Limited
      11.7. Genotypic Technology Pvt. Ltd.
      11.8. GENEWIZ, Inc.
      11.9. Beijing Genomics Institute (BGI)
      11.10. SciGenom Labs Pvt. Ltd
      11.11. MedGenome Inc.
      11.12. DNA Link, Inc.
      11.13. Otogenetics Corporation
      11.14. Novogene Corporation
      11.15. CD Genomics
      11.16. SeqLL Inc.

12. Appendix
      12.1. Questionnaire
      12.2. Available Customization

List of Tables

Table 1 Currency Conversion Rate, 2016-2018
Table 2 Reduction in Cost of Genome Sequencing: 2008-2018
Table 3 Technological Advancements in NGS Services Market
Table 4 Global NGS Services Market Size, by Service Type, 2017-2025 ($Million)
Table 5 Global Targeted Sequencing Services Market Size, by Country/Region, 2017-2025 ($Million)
Table 6 Global RNA Sequencing Services Market Size, by Country/Region, 2017-2025 ($Million)
Table 7 Global Exome Sequencing Services Market Size, by Country/Region, 2017-2025 ($Million)
Table 8 Global De Novo Sequencing Services Market Size, by Country/Region, 2017-2025 ($Million)
Table 9 Global ChIP Sequencing Services Market Size, by Country/Region, 2017-2025 ($Million)
Table 10 Global Whole Genome Sequencing Services Market Size, by Country/Region, 2017-2025 ($Million)
Table 11 Global Methyl Sequencing Services Market Size, by Country/Region, 2017-2025 ($Million)
Table 12 Global Other Sequencing Services Market Size, by Country/Region, 2017-2025 ($Million)
Table 13 Global NGS Services Market Size, by Technology, 2017-2025 ($Million)
Table 14 Global Sequencing by Synthesis Services Market Size, by Country/Region, 2017-2025 ($Million)
Table 15 Global Ion Semiconductor Sequencing Services Market Size, by Country/Region, 2017-2025 ($Million)
Table 16 Global Single Molecule Real Time Services Market Size, by Country/Region, 2017-2025 ($Million)
Table 17 Global Nanopore Sequencing Services Market Size, by Country/Region, 2017-2025 ($Million)
Table 18 Global True Single Molecule Sequencing Services Market Size, by Country/Region, 2017-2025 ($Million)
Table 19 Global NGS Services Market Size, by Application, 2017-2025 ($Million)
Table 20 Global NGS Services Market Size for Diagnostics, by Country/Region, 2017-2025 ($Million)
Table 21 Global NGS Services Market Size for Drug Discovery, by Country/Region, 2017-2025 ($Million)
Table 22 Global NGS Services Market Size for Biomarker Discovery, by Country/Region, 2017-2025 ($Million)
Table 23 Global NGS Services Market Size for Agriculture and Animal Research, by Country/Region, 2017-2025 ($Million)
Table 24 Global NGS Services Market Size for Other Applications, by Country/Region, 2017-2025 ($Million)
Table 25 Global NGS Services Market Size, by End User, 2017-2025 ($Million)
Table 26 Global NGS Services Market Size for Hospitals & Clinics, by Country/Region, 2017-2025 ($Million)
Table 27 Global NGS Services Market Size for Pharmaceuticals & Biotechnology Companies, by Country/Region, 2017-2025 ($Million)
Table 28 Global NGS Services Market Size for Academic & Research Institutes, by Country/Region, 2017-2025 ($Million)
Table 29 Global NGS Services Market Size for Other End Users, by Country/Region, 2017-2025 ($Million)
Table 30 Global NGS Services Market Size, by Country/Region, 2017-2025 ($Million)
Table 31 North America: NGS Services Market Size, by Country, 2017-2025 ($Million)
Table 32 North America: NGS Services Market Size, by Service Type, 2017-2025 ($Million)
Table 33 North America: NGS Services Market Size, by Technology, 2017-2025 ($Million)
Table 34 North America: NGS Services Market Size, by Application, 2017-2025 ($Million)
Table 35 North America: NGS Services Market Size, by End User, 2017-2025 ($Million)
Table 36 U.S.: Key Macroindicators
Table 37 U.S.: NGS Services Market Size, by Service Type, 2017-2025 ($Million)
Table 38 U.S.: NGS Services Market Size, by Technology, 2017-2025 ($Million)
Table 39 U.S.: NGS Services Market Size, by Application, 2017-2025 ($Million)
Table 40 U.S.: NGS Services Market Size, by End User, 2017-2025 ($Million)
Table 41 Canada: Key Macroindicators
Table 42 Canada: NGS Services Market Size, by Service Type, 2017-2025 ($Million)
Table 43 Canada: NGS Services Market Size, by Technology, 2017-2025 ($Million)
Table 44 Canada: NGS Services Market Size, by Application, 2017-2025 ($Million)
Table 45 Canada: NGS Services Market Size, by End User, 2017-2025 ($Million)
Table 46 Europe: NGS Services Market Size, by Country/Region, 2017-2025 ($Million)
Table 47 Europe: NGS Services Market Size, by Service Type, 2017-2025 ($Million)
Table 48 Europe: NGS Services Market Size, by Technology, 2017-2025 ($Million)
Table 49 Europe: NGS Services Market Size, by Application, 2017-2025 ($Million)
Table 50 Europe: NGS Services Market Size, by End User, 2017-2025 ($Million)
Table 51 Germany: Key Macroindicators
Table 52 Germany: NGS Services Market Size, by Service Type, 2017-2025 ($Million)
Table 53 Germany: NGS Services Market Size, by Technology, 2017-2025 ($Million)
Table 54 Germany: NGS Services Market Size, by Application, 2017-2025 ($Million)
Table 55 Germany: NGS Services Market Size, by End User, 2017-2025 ($Million)
Table 56 France: Key Macroindicators
Table 57 France: NGS Services Market Size, by Service Type, 2017-2025 ($Million)
Table 58 France: NGS Services Market Size, by Technology, 2017-2025 ($Million)
Table 59 France: NGS Services Market Size, by Application, 2017-2025 ($Million)
Table 60 France: NGS Services Market Size, by End User, 2017-2025 ($Million)
Table 61 U.K.: Key Macroindicators
Table 62 U.K.: NGS Services Market Size, by Service Type, 2017-2025 ($Million)
Table 63 U.K.: NGS Services Market Size, by Technology, 2017-2025 ($Million)
Table 64 U.K.: NGS Services Market Size, by Application, 2017-2025 ($Million)
Table 65 U.K.: NGS Services Market Size, by End User, 2017-2025 ($Million)
Table 66 Italy: Key Macroindicators
Table 67 Italy: NGS Services Market Size, by Service Type, 2017-2025 ($Million)
Table 68 Italy: NGS Services Market Size, by Technology, 2017-2025 ($Million)
Table 69 Italy: NGS Services Market Size, by Application, 2017-2025 ($Million)
Table 70 Italy: NGS Services Market Size, by End User, 2017-2025 ($Million)
Table 71 Spain: Key Macroindicators
Table 72 Spain: NGS Services Market Size, by Service Type, 2017-2025 ($Million)
Table 73 Spain: NGS Services Market Size, by Technology, 2017-2025 ($Million)
Table 74 Spain: NGS Services Market Size, by Application, 2017-2025 ($Million)
Table 75 Spain: NGS Services Market Size, by End User, 2017-2025 ($Million)
Table 76 RoE: NGS Services Market Size, by Service Type, 2017-2025 ($Million)
Table 77 RoE: NGS Services Market Size, by Technology, 2017-2025 ($Million)
Table 78 RoE: NGS Services Market Size, by Application, 2017-2025 ($Million)
Table 79 RoE: NGS Services Market Size, by End User, 2017-2025 ($Million)
Table 80 APAC: NGS Services Market Size, by Country/Region, 2017-2025 ($Million)
Table 81 APAC: NGS Services Market Size, by Service Type, 2017-2025 ($Million)
Table 82 APAC: NGS Services Market Size, by Technology, 2017-2025 ($Million)
Table 83 APAC: NGS Services Market Size, by Application, 2017-2025 ($Million)
Table 84 APAC: NGS Services Market Size, by End User, 2017-2025 ($Million)
Table 85 Japan: Key Macroindicators
Table 86 Japan: NGS Services Market Size, by Service Type, 2017-2025 ($Million)
Table 87 Japan: NGS Services Market Size, by Technology, 2017-2025 ($Million)
Table 88 Japan: NGS Services Market Size, by Application, 2017-2025 ($Million)
Table 89 Japan: NGS Services Market Size, by End User, 2017-2025 ($Million)
Table 90 China: Key Macroindicators
Table 91 China: NGS Services Market Size, by Service Type, 2017-2025 ($Million)
Table 92 China: NGS Services Market Size, by Technology, 2017-2025 ($Million)
Table 93 China: NGS Services Market Size, by Application, 2017-2025 ($Million)
Table 94 China: NGS Services Market Size, by End User, 2017-2025 ($Million)
Table 95 India: Key Macroindicators
Table 96 India: NGS Services Market Size, by Service Type, 2017-2025 ($Million)
Table 97 India: NGS Services Market Size, by Technology, 2017-2025 ($Million)
Table 98 India: NGS Services Market Size, by Application, 2017-2025 ($Million)
Table 99 India: NGS Services Market Size, by End User, 2017-2025 ($Million)
Table 100 RoAPAC: NGS Services Market Size, by Service Type, 2017-2025 ($Million)
Table 101 RoAPAC: NGS Services Market Size, by Technology, 2017-2025 ($Million)
Table 102 RoAPAC: NGS Services Market Size, by Application, 2017-2025 ($Million)
Table 103 RoAPAC: NGS Services Market Size, by End User, 2017-2025 ($Million)
Table 104 Latin America: NGS Services Market Size, by Service Type, 2017-2025 ($Million)
Table 105 Latin America: NGS Services Market Size, by Technology, 2017-2025 ($Million)
Table 106 Latin America: NGS Services Market Size, by Application, 2017-2025 ($Million)
Table 107 Latin America: NGS Services Market Size, by End User, 2017-2025 ($Million)
Table 108 Middle East & Africa: NGS Services Market Size, by Service Type, 2017-2025 ($Million)
Table 109 Middle East & Africa: NGS Services Market Size, by Technology, 2017-2025 ($Million)
Table 110 Middle East & Africa: NGS Services Market Size, by Application, 2017-2025 ($Million)
Table 111 Middle East & Africa: NGS Services Market Size, by End User, 2017-2025 ($Million)
Table 112 Recent Developments, by Company, 2016-2019

List of Figures

Figure 1 Research Process
Figure 2 Key Executives Interviewed
Figure 3 Primary Research Techniques
Figure 4 Market Size Estimation
Figure 5 Key Insights
Figure 6 Meticulous Research Estimates: Targeted Sequencing Vs. Whole Genome Sequencing
Figure 7 Meticulous Research Estimates: Sequencing by Synthesis Vs. Single Molecule Real Time Sequencing
Figure 8 Meticulous Research Estimates: Diagnostics Vs. Biomarker Discovery
Figure 9 Hospitals & Clinics Expected to Dominate the Global NGS Services Market, by End User (2019-2025)
Figure 10 NGS Services Market, by Region
Figure 11 Market Dynamics
Figure 12 Total Number of Sequences in the GenomeTrakr Database
Figure 13 Global NGS Services Market Size, by Service Type, 2019-2025 ($Million)
Figure 14 Funding for Targeted Sequencing Services
Figure 15 Global NGS Services Market Size, by Technology, 2019-2025 ($Million)
Figure 16 Global NGS Services Market Size, by Application, 2019-2025 ($Million)
Figure 17 Global NGS Services Market Size, by End User, 2019-2025 ($Million)
Figure 18 Global Pharmaceutical R&D Spending, 2013-2017
Figure 19 Global NGS Services Market Size, by Geography, 2019-2025 ($Million)
Figure 20 Number of Biotechnology Firms in Italy, 2005-2018
Figure 21 R&D Spending by Pharmaceutical Industry in Spain, 2008-2016
Figure 22 Key Growth Strategies Adopted by Leading Players -2016-2019
Figure 23 NGS Services: Competitive Benchmarking
Figure 24 Market Share Analysis: Next Generation Sequencing Services Industry, 2018
Figure 25 Illumina, Inc.: Financial Overview (2016-2018)
Figure 26 Qiagen N.V.: Financial Overview (2016-2018)
Figure 27 PerkinElmer, Inc.: Financial Overview (2016-2018)
Figure 28 Eurofins Scientific SE: Financial Overview (2016-2018)
Figure 29 Macrogen, Inc.: Financial Overview (2016-2018)
Figure 30 LGC Limited: Financial Overview (2017-2018)

The global Next-generation Sequencing (NGS) Services Market is expected to grow at a CAGR of 20.5% from 2019 to reach $13.1 billion by 2025.

The field of genomics has surpassed expectations over the past three decades due to massive changes in technology that allowed researchers to investigate and study larger pieces of the human genome. By lowering costs and enabling the production of scientifically useful quantities of DNA sequence data in manageable timeframes, next-generation sequencing technologies are helping researchers across the globe to fully realize the promise of genomics and sequencing.

Over the years, numerous collaborative projects and consortia have emerged to understand the structure of genomes in more detail; catalog genetic variation; and to identify the genetic causes of disease across animal, plant, and microbial species. These efforts have revolutionized the understanding of diseases, enabling development of better diagnosis and treatment platforms. Despite the fact that NGS platforms are still technically maturing, the technology has progressively entered into the clinical molecular laboratories, driven by the growing acceptance of the technology among physicians, pathologists, molecular biologists, scientists, and clinical administrators.

Increase in genome mapping programs are propelling the growth of NGS services market

The wide use of next-generation sequencing (NGS) for genome sequencing requires the proper mapping of each read generated during the sequencing process. The use of genetic techniques to construct map showing the position of gene and other sequence features on a genome are some of the major driving factors for genomics research, globally. To understand the mapping of individual genome, researchers are collaborating and are initiating various genome mapping programs in several countries. For instance,

  • In December 2017, China launched 100,000 Genomes Project, which intends to sequence the genomes of 100,000 people from different ethnic backgrounds and regions across China to study transformation of population from health to disease, environmental impacts, and the interactions between environmental factors and genes.
  • In France, French Plan also known as Genomic Medicine 2025 was launched in 2015 with public financing of $743.5 million (€670 million) by year 2020. The program aimed to increase personalised and precision medicine development by integrating genomic medicine (using NGS) into healthcare pathways. Also, under the program, genome sequencing was performed by 12 ultra-high throughput services to enable sequencing of 235,000 genomes per year by 2020.

Increasing applications in cancer and agrigenomics research offers significant opportunities to support the market growth

Next-generation sequencing (NGS) technologies including DNA sequencing and RNA sequencing provide “omics” approaches to reveal genomic, transcriptomic, and epigenomic landscapes of individual cancers. Using NGS, a variety of genomic aberrations can be screened simultaneously, such as common and rare variants, structural variations (e.g. insertions and deletions), copy-number variation, and fusion transcripts.

Whole exome sequencing (WES), a targeted sequencing method, is routinely used and is gradually being optimized for the detection of rare and common genetic variants in humans. The exome represents less than 2% of the genome, and thus WES reduces the cost to sequence a targeted region at a high depth and reduces storage and analysis costs. WES provides comprehensive exome sequencing to identify exact pathogenic mutations for the disease with a low frequency of false positive signals.

Advanced genomic technologies are also used to help scientists to obtain and understand the genomic information or DNA retrieved from common crops and livestock in agriculture. For instance, CEN4GEN (Genome research service provider for diverse applications, including agriculture genomics) helps farmers, breeders and scientists to identify genetic medical conditions, as well as desirable or advantageous traits that would benefit crop and livestock production. Thus, increasing adoption of NGS technology in agriculture to enhance plant resistance to diseases, plant breeding, and increase yield of livestock provides great potential for NGS services market.

Next Generation Sequencing Services Market

Click here to : Get Free Sample Pages of this Report

Key findings in the global NGS services market study:

The targeted sequencing segment is estimated to command the largest share of the overall NGS services market in 2019

In comparison with the whole genome sequencing, targeted sequencing has many advantages to offer to the researchers in terms of the cost, time, and data analysis of a specific area of interest. For instance, a whole genome sequencing technology covers a target region at 30x-50x per genome; while the targeted sequencing covers 500x-1000x per genome. Such higher coverage enables researchers to identify the variants that are rare. One of the common applications of targeted sequencing is the detection & validation of single nucleotide polymorphism (SNP) which is considered as an important aspect of genome analysis.

Targeted sequencing is increasingly gaining popularity among the researchers, owing to its low cost and other benefits it has to offer. The increasing adoption of targeted sequencing has also led to its use in biomarker discovery, which is used to identify the clinically suitable targets in the field of translational research. Also, targeted sequencing is particularly useful for discovery of somatic mutations in complex samples such as cancerous tumors mixed with germline DNA. As the impact of targeted resequencing continues to grow, the number of grants and funding for research involving targeted sequencing is also on the rise.

Diagnostic application witnesses the largest demand through 2025

The next generation sequencing technology is witnessing rapid evolution and is increasingly being used for diagnosis and monitoring of rare genetic disorders, infectious diseases, and cancer across the globe. According to the National Cancer Institute, in 2018, more than 1.7 million people in the U.S. were diagnosed with cancer. According to the American Association for Cancer Research, the number of new cancer cases per year is expected to be almost 2.4 million in the U.S., and 24 million globally, by 2035.

The growing cancer incidence, globally, needs appropriate methods for diagnosis in early stage; and molecular diagnostics has the potential to address this concern and reduce the burden of cancer in the future. Molecular diagnostics would not only help to improve health care by using NGS technology for the detection of mutation, but also in reducing financial burden of cancer. For instance, in the U.S., the cost of cancer care in 2017 was estimated to be $125.0 billion. These costs were projected to increase to $157.77 billion in 2020, which is a 27% increase over 2010. The Centers for Disease Control and Prevention (CDC), through its Advanced Molecular Detection Program, has supported the adoption of NGS and whole genome sequencing (WGS) by providing funding and training to PHLs.

Asia-Pacific: The fastest growing regional market

North America commanded the largest share of the global next generation sequencing services market in 2018, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. However, Asia-Pacific region is expected to grow at the higher CAGR during the forecast period, primarily due to accelerated growth of economies; increasing incidence of infectious and non-communicable diseases with aging population; various government initiatives for the genomic research to understands the complex biological process and genetic mutations present in life threatening diseases; increasing investments by the major players; availability of research funding; improvement in healthcare infrastructures; and growing outsourcing activities in the region.

Key Players

The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2016-2019). The key players profiled in the global NGS services market report are Illumina, Inc. (U.S.), Qiagen N.V. (The Netherlands), PerkinElmer, Inc. (U.S.), Eurofins Scientific SE (Luxembourg), Macrogen, Inc. (South Korea), Genotypic Technology Pvt. Ltd. (India), GENEWIZ, Inc. (U.S.), Beijing Genomics Institute (BGI) (China), SciGenom Labs Pvt. Ltd. (India), MedGenome (U.S.), DNA Link, Inc. (South Korea), Otogenetics Corporation (U.S.), Novogene Corporation (China), LGC Limited (U.K.), CD Genomics (U.S.), and SeqLL, LLC (U.S.).

Scope of the Report:

Next-Generation Sequencing Services Market, by Service Type

  • Targeted Sequencing
  • RNA Sequencing
  • Exome Sequencing
  • De Novo Sequencing
  • ChIP-Sequencing
  • Methyl Sequencing
  • Whole Genome Sequencing
  • Other Services

 Next-Generation Sequencing Services Market, by Technology

  • Sequencing by Synthesis (SBS)
  • Ion Semiconductor Sequencing (IOS)
  • Single Molecule Real Time Sequencing (SMRT)
  • Nanopore Sequencing
  • True Single Molecule Sequencing (tSMS)

 Next-Generation Sequencing Services Market, by Application

  • Diagnostics
  • Drug Discovery
  • Biomarker Discovery
  • Agriculture & Animal Research
  • Other Applications

 Next-Generation Sequencing Services Market, by End User

  • Hospitals & Clinics
  • Pharmaceuticals & Biotechnology Industry
  • Academics & Research Institutes
  • Other End Users

 Next-Generation Sequencing Services Market, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Latin America
  • Middle East & Africa

Key questions answered in the report-

Increase in genome mapping program in NGS services will propel the NGS services market

  • How do the increasing genome mapping programs drive the growth of NGS services market?
  • How government initiatives and investment in genome mapping programs bolstering the NGS services market in developing and developed regions.

Targeted sequencing accounted for the largest share of the NGS services market

  • What factors are contributing to the frequent usage of targeted sequencing among various services?
  • How does the adoption of targeted sequencing differ from other services?

The Asia-Pacific NGS services market favors both larger and local manufacturers that compete in multiple segments

  • Whoare the top competitors in this market and what strategies do they employ to gain shares?
  • What factors are driving growth and which market segments have the most potential for revenue expansion over the forecast period?
  • What strategies should new companies look to enter this market use to compete effectively?
  • What are the major drivers, restraints, challenges, and opportunities, in the global NGS services market?
  • Who are the major players in various countries and what share of the global market do they hold?
  • What are the geographical trends and high growth regions/countries?
This website is secure and we do not share your personal information with any third party. Privacy Policy
Tags: Next Generation Sequencing Services Market Technology Agriculture Sequencing Technologies Healthcare Healthcare IT
Download Free Sample